Y-mabs Therapeutics, Inc.
Pharmaceutical Preparations
230 Park Avenue, Suite 3350, New York, NY, 10169 Insider Ownership
Above 5% Ownership
- SC 13G/A
- SC 13G/A
- SC 13G/A
- SC 13G/A
- SC 13G/A
- SC 13G/A
- SC 13G/A
- SC 13G/A
- SC 13G/A
- SC 13G/A
- SC 13G/A
- SC 13G/A
- SC 13G/A
- SC 13G
- 4
- SC 13D/A
- 4
- SC 13D/A
- SC 13D
- SC 13D
- SC 13G
- SC 13G/A
- SC 13G
- SC 13G/A
- D
- SC 13G/A
- SC 13G/A
- SC 13G/A
- SC 13G/A
- SC 13G
Ahmed Mahiuddin
Ahmed Mahiuddin
27 May 20
Ahmed Mahiuddin
20 May 20
Ahmed Mahiuddin
15 May 20
Ahmed Mahiuddin
13 May 20
Ahmed Mahiuddin
09 Jan 20
Ber Gerard
Ber Gerard
15 May 23
Ber Gerard
10 May 22
Ber Gerard
23 Jun 20
Ber Gerard
23 Jun 20
Ber Gerard
14 Jun 19
Buschle Michael
Buschle Michael
20 Sep 18
Gad Thomas
Gad Thomas
15 Dec 23
Report With Error Fetching Owner Name
22 Nov 23
Gad Thomas
19 Aug 20
Gad Thomas
29 May 20
Gad Thomas
06 Aug 19
Gill David N
Gill David N
09 Jun 23
Gill David N
06 Oct 21
Gill David N
24 Jun 20
Gill David N
05 Jan 17
Initial Statement Of Beneficial Ownership.
19 Jun 02
Hamill Laura
Hamill Laura
10 Jan 23
Hamill Laura
22 Nov 21
Hamill Laura
14 Jun 21
Hamill Laura
13 Feb 20
Hamill Laura
18 Sep 18
Healy James
Healy James
11 Feb 22
Healy James
02 Jul 19
Sofinnova Management Viii, L.l.c.
15 Sep 14
Healy James
19 Jul 12
Healy James
19 Jan 06
Herman Philip Karl
Herman Philip Karl
16 Dec 20
Herman Philip Karl
24 Jun 20
Herman Philip Karl
09 Jan 20
Kruse Bo
Kruse Bo
30 May 24
Kruse Bo
07 Dec 21
Kruse Bo
05 Oct 21
Kruse Bo
16 Dec 20
Kruse Bo
13 Dec 18
Lisby Steen
Lisby Steen
22 Jan 24
Lisby Steen
30 Jan 23
Lisby Steen
28 Apr 22
Lisby Steen
16 Dec 21
Lisby Steen
20 Sep 18
Lund-hansen Torben
Lund-hansen Torben
22 Jan 24
Lund-hansen Torben
30 Jan 23
Lund-hansen Torben
28 Apr 22
Lund-hansen Torben
16 Dec 20
Lund-hansen Torben
20 Sep 18
Moller-san Pedro Claus Juan
Moller-san Pedro Claus Juan
16 Dec 21
Moller-san Pedro Claus Juan
16 Dec 20
Moller-san Pedro Claus Juan
15 May 20
Juan Moller San Pedro Claus
13 Dec 18
Juan Moller San Pedro Claus
25 Sep 18
Rajah Vignesh
Rajah Vignesh
28 Apr 22
Rajah Vignesh
13 Aug 21
Rajah Vignesh
04 Dec 20
Rajah Vignesh
24 Jun 20
Rajah Vignesh
12 Jun 20
Raskin Gregory S
Raskin Gregory S
29 Aug 19
Raskin Gregory S
14 Jun 19
Raskin Gregory S
20 Sep 18
Rossi Michael J
Rossi Michael J
14 Feb 24
Rossi Michael J
08 Nov 23
Rossi Michael J
31 Mar 23
Rossi Michael J
03 Nov 22
Rossi Michael J
06 Oct 22
Smith Susan Laura
Smith Susan Laura
07 Mar 24
Smith Susan Laura
06 Mar 24
Smith Susan Laura
22 Jan 24
Smith Susan Laura
30 Jan 23
Smith Susan Laura
28 Apr 22
Tagliaferri Mary
Tagliaferri Mary
13 Jun 24
Tagliaferri Mary
02 Feb 24
Amended Statement Of Beneficial Ownership Of More Than 5%.
21 Feb 07
Tagliaferri Mary
07 Jun 06
Acquired More Than 5% Ownership Of Any Class Of A Company's Securities.
13 Apr 05
Tyagi Ashu
Tyagi Ashu
19 Jul 22
Tyagi Ashu
14 Jun 21
Tyagi Ashu
24 Jun 20
Tyagi Ashu
14 Jun 19
Tyagi Ashu
26 Sep 18
Wedell-wedellsborg Johan
Wedell-wedellsborg Johan
01 Dec 23
Wedell-wedellsborg Johan
14 Jun 21
Wedell-wedellsborg Johan
09 Jun 21
Wedell-wedellsborg Johan
24 Jun 20
Wedell-wedellsborg Johan
31 Dec 19
Wg Biotech Aps
Wg Biotech Aps
29 Nov 23
14 Feb 23
Wg Biotech Aps
10 Jun 21
Wg Biotech Aps
07 Jun 21
Wg Biotech Aps
20 Sep 18
Hbm Healthcare Investments (cayman) Ltd.
Hbm Healthcare Investments (cayman) Ltd.
09 Aug 17
Hbm Healthcare Investments (cayman) Ltd.
02 Oct 14
14 Feb 14
Amended Statement Of Beneficial Ownership Of More Than 5%.
13 Feb 14
Hbm Bioventures Cayman Ltd
23 Jun 08
Wellington Management Group Llp
12 Feb 19
12 Mar 12
14 Feb 08
12 Feb 02
13 Feb 01
Cheung Nai-kong V
27 Aug 20
26 Aug 20
Vanguard Group Inc
11 Feb 19
11 Feb 16
10 Feb 16
12 Feb 14
12 Feb 14
Wg Biotech Aps
Wg Biotech Aps
29 Nov 23
14 Feb 23
Wg Biotech Aps
10 Jun 21
Wg Biotech Aps
07 Jun 21
Wg Biotech Aps
20 Sep 18
Paradigm Biocapital Advisors Lp
14 Nov 24
14 Nov 24
14 Feb 24
22 Jan 24
Paradigm Biocapital Advisors Lp
08 Dec 23
Sofinnova Venture Partners X, L.p.
Amended Statement Of Beneficial Ownership Of More Than 5%.
01 Mar 23
Healy James
27 Feb 23
Amended Statement Of Beneficial Ownership Of More Than 5%.
14 Feb 23
Acquired More Than 5% Ownership Of Any Class Of A Company's Securities.
24 May 21
Acquired More Than 5% Ownership Of Any Class Of A Company's Securities.
03 Jul 19
Acorn Bioventures, L.p.
14 Feb 24
13 Feb 24
01 Sep 23
Amended Statement Of Beneficial Ownership Of More Than 5%.
26 Jan 23
Notice Of An Exempt Offering Of Securities Under Regulation D.
01 Mar 19
Memorial Sloan Kettering Cancer Center
Quarterly Holdings Report
14 Nov 23
Quarterly Holdings Report
10 Feb 23
Quarterly Holdings Report
16 Aug 21
Memorial Sloan-kettering Cancer Center
02 Jun 16
Memorial Sloan-kettering Cancer Center
26 May 16
Blackrock Inc.
31 Jan 19
30 Jan 19
08 Jul 16
04 Feb 11
09 Feb 07